Targeting Different Monocyte/Macrophage Subsets Has No Impact on Outcome in Experimental Stroke

Stroke

Volumn 48, Issue 4, 2017, Pages 1061-1069

  Schmidt, Antje ^a   Strecker, Jan Kolja ^a   Hucke, Stephanie ^a   Bruckmann, Nils Martin ^a   Herold, Martin ^a   MacK, Matthias ^b   Diederich, Kai ^a   Schäbitz, Wolf Rüdiger ^c   Wiendl, Heinz ^a   Klotz, Luisa ^a   Minnerup, Jens ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

Animal; Inflammation; Macrophages; Models; Monocytes; Stroke

Indexed keywords

CHEMOKINE RECEPTOR CCR2 ANTAGONIST; CLODRONIC ACID; MC 21 ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL SUBPOPULATION; CELL TRANSPLANTATION; CONTROLLED STUDY; EXPERIMENTAL CEREBRAL ISCHEMIA; MACROPHAGE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOCYTE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; TISSUE INJURY; ANIMAL; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; COMPLICATION; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; RANDOMIZATION; STROKE;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; MACROPHAGES; MICE; MONOCYTES; RANDOM ALLOCATION; STROKE;

EID: 85015253564     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.116.015577     Document Type: Article

References (38)

1. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17:796-808. doi: 10.1038/nm.2399.
2. Magnus T, Wiendl H, Kleinschnitz C. Immune mechanisms of stroke. Curr Opin Neurol. 2012;25:334-340. doi: 10.1097/WCO.0b013e328352ede6.
3. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke. 2009;40:1849-1857. doi: 10.1161/STROKEAHA.108.534503.
4. Liesz A, Zhou W, Mracskó É, Karcher S, Bauer H, Schwarting S, et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain. 2011;134(pt 3):704-720. doi: 10.1093/brain/awr008.
5. Neumann J, Riek-Burchardt M, Herz J, Doeppner TR, König R, Hütten H, et al. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke. Acta Neuropathol. 2015;129:259-277. doi: 10.1007/s00401-014-1355-2.
6. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med. 2009;15:946-950. doi: 10.1038/nm.1999.
7. Gliem M, Mausberg AK, Lee JI, Simiantonakis I, van Rooijen N, Hartung HP, et al. Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann Neurol. 2012;71:743-752. doi: 10.1002/ana.23529.
8. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29:13435-13444. doi: 10.1523/JNEUROSCI.3257-09.2009.
9. Hilgendorf I, Gerhardt LM, Tan TC, Winter C, Holderried TA, Chousterman BG, et al. Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res. 2014;114:1611-1622. doi: 10.1161/CIRCRESAHA.114.303204.
10. Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation. 2010;121:2437-2445. doi: 10.1161/CIRCULATIONAHA. 109.916346.
11. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. 2007;204:3037-3047. doi: 10.1084/jem.20070885.
12. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958-969. doi: 10.1038/nri2448.
13. Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G, et al. Infiltrating blood-derived macrophages are vital cells playing an antiinflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009;6:e1000113. doi: 10.1371/journal.pmed.1000113.
14. van Amerongen MJ, Harmsen MC, van Rooijen N, Petersen AH, van Luyn MJ. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol. 2007;170:818-829. doi: 10.2353/ajpath.2007.060547.
15. Schilling M, Strecker JK, Ringelstein EB, Kiefer R, Schäbitz WR. Turnover of meningeal and perivascular macrophages in the brain of MCP-1-, CCR-2-or double knockout mice. Exp Neurol. 2009;219:583-585. doi: 10.1016/j.expneurol.2009.07.003.
16. Chu HX, Broughton BR, Kim HA, Lee S, Drummond GR, Sobey CG. Evidence that Ly6C(hi) monocytes are protective in acute ischemic stroke by promoting M2 macrophage polarization. Stroke. 2015;46:1929-1937. doi: 10.1161/STROKEAHA.115.009426.
17. Desestret V, Riou A, Chauveau F, Cho TH, Devillard E, Marinescu M, et al. In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages. PLoS One. 2013;8:e67063. doi: 10.1371/journal.pone.0067063.
18. Racoosin EL, Swanson JA. Macrophage colony-stimulating factor (rMCSF) stimulates pinocytosis in bone marrow-derived macrophages. J Exp Med. 1989;170:1635-1648.
19. Hucke S, Flodorf J, Grützke B, Dunay IR, Frenzel K, Jungverdorben J, et al. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor . Brain. 2012;135(pt 5):1586-1605. doi: 10.1093/brain/aws058.
20. Menzies SA, Hoff JT, Betz AL. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery. 1992;31:100-106, discussion 106.
21. Minnerup J, Wagner DC, Strecker JK, Pösel C, Sevimli-Abdis S, Schmidt A, et al. Bone marrow-derived mononuclear cells do not exert acute neuroprotection after stroke in spontaneously hypertensive rats. Front Cell Neurosci. 2014;7:288. doi: 10.3389/fncel.2013.00288.
22. Mack M, Cihak J, Simonis C, Luckow B, Proudfoot AE, Plachý J, et al. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol. 2001;166:4697-4704.
23. Minnerup J, Kim JB, Schmidt A, Diederich K, Bauer H, Schilling M, et al. Effects of neural progenitor cells on sensorimotor recovery and endogenous repair mechanisms after photothrombotic stroke. Stroke. 2011;42:1757-1763. doi: 10.1161/STROKEAHA.110.599282.
24. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature. 2010;468:305-309. doi: 10.1038/nature09511.
25. Frith JC, Mönkkönen J, Blackburn GM, Russell RG, Rogers MJ. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res. 1997;12:1358-1367. doi: 10.1359/jbmr.1997.12.9.1358.
26. Strecker JK, Olk J, Hoppen M, Gess B, Diederich K, Schmidt A, et al. Combining growth factor and bone marrow cell therapy induces bleeding and alters immune response after stroke in mice. Stroke. 2016;47:852-862. doi: 10.1161/STROKEAHA.115.011230.
27. Khallou-Laschet J, Varthaman A, Fornasa G, Compain C, Gaston AT, Clement M, et al. Macrophage plasticity in experimental atherosclerosis. PLoS One. 2010;5:e8852. doi: 10.1371/journal.pone.0008852.
28. Schmidt A, Hoppen M, Strecker JK, Diederich K, Schäbitz WR, Schilling M, et al. Photochemically induced ischemic stroke in rats. Exp Transl Stroke Med. 2012;4:13. doi: 10.1186/2040-7378-4-13.
29. Boche D, Perry VH, Nicoll JA. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol. 2013;39:3-18. doi: 10.1111/nan.12011.
30. Patel AR, Ritzel R, McCullough LD, Liu F. Microglia and ischemic stroke: a double-edged sword. Int J Physiol Pathophysiol Pharmacol. 2013;5:73-90.
31. Miró-Mur F, Pérez-de-Puig I, Ferrer-Ferrer M, Urra X, Justicia C, Chamorro A, et al. Immature monocytes recruited to the ischemic mouse brain differentiate into macrophages with features of alternative activation. Brain Behav Immun. 2016;53:18-33. doi: 10.1016/j.bbi.2015.08.010.
32. Ritzel RM, Patel AR, Grenier JM, Crapser J, Verma R, Jellison ER, et al. Functional differences between microglia and monocytes after ischemic stroke. J Neuroinflammation. 2015;12:106. doi: 10.1186/s12974-015-0329-1.
33. Benakis C, Garcia-Bonilla L, Iadecola C, Anrather J. The role of microglia and myeloid immune cells in acute cerebral ischemia. Front Cell Neurosci. 2014;8:461. doi: 10.3389/fncel.2014.00461.
34. Ma Y, Li Y, Jiang L, Wang L, Jiang Z, Wang Y, et al. Macrophage depletion reduced brain injury following middle cerebral artery occlusion in mice. J Neuroinflammation. 2016;13:38. doi: 10.1186/s12974-016-0504-z.
35. Perego C, Fumagalli S, Zanier ER, Carlino E, Panini N, Erba E, et al. Macrophages are essential for maintaining a M2 protective response early after ischemic brain injury. Neurobiol Dis. 2016;96:284-293. doi: 10.1016/j.nbd.2016.09.017.
36. Schilling M, Strecker JK, Ringelstein EB, Schäbitz WR, Kiefer R. The role of CC chemokine receptor 2 on microglia activation and bloodborne cell recruitment after transient focal cerebral ischemia in mice. Brain Res. 2009;1289:79-84. doi: 10.1016/j.brainres.2009.06.054.
37. Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke. 2007;38:1345-1353. doi: 10.1161/01. STR.0000259709.16654.8f.
38. Wattananit S, Tornero D, Graubardt N, Memanishvili T, Monni E, Tatarishvili J, et al. Monocyte-derived macrophages contribute to spontaneous long-term functional recovery after stroke in mice. J Neurosci. 2016;36:4182-4195. doi: 10.1523/JNEUROSCI.4317-15.2016.